Product Details

Jamp Amoxi Clav Suspension

Amoxicillin + Clavulanic Acid
50 mg + 12.5 mg/mL
Powder for Oral Suspension


DIN/PIN/NPN

02539438

Manufacturer

Jamp Pharma Corporation

Formulary Listing Date

2024-09-27  

Unit Price

0.1216

Amount MOH Pays

0.1216

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.

ATC Code

J01CR02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
01916874 Clavulin 0.2554 0.1216
02542226 M-Amoxi Clav 0.1216 0.1216
02539438 Jamp Amoxi Clav Suspension 0.1216 0.1216
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph